HKSE · 1501.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Shanghai Kindly Medical Instruments Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai Kindly Medical Instruments Co., Ltd.’s forward annual dividend is HK$0.30 per share, paid annual. The forward yield is 1.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shanghai Kindly Medical Instruments Co., Ltd.’s next earnings report is currently expected on Mar 22, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Kindly Medical Instruments Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai Kindly Medical Instruments Co., Ltd., founded in 2006 and based in Shanghai, China, focuses on the research, development, production, and international sales of cardiovascular interventional medical devices. The company's products reach customers across Mainland China, Europe, the United States, and various other global regions. Its comprehensive range of interventional instruments includes guiding catheters, which facilitate the introduction of balloon catheters, guidewires, or other therapeutic tools; micro catheters, offering support for guidewire placement; and guidewires themselves, integral to percutaneous transluminal angioplasty (PTA) surgical procedures. The portfolio also features angiography catheters for injecting contrast media and fluids, along with Y-connector packs specifically designed for PTCA surgery. Further product offerings comprise inflation devices, essential for balloon inflation during vessel dilation or stent deployment; single-use manifolds and manifold kits; and pressure bandages utilized for compression hemostasis. The company additionally manufactures single-use angiography syringes, stopcocks for surgical pressure monitoring, sterile Seldinger needles for arterial puncture, introducer sets, single-use pressure transducers, extension tubes for pressure monitoring, and introducer tool kits employed in percutaneous vertebroplasty. Beyond these specialized tools, Shanghai Kindly Medical Instruments provides a variety of medical accessories, such as check valves, needle-free connectors, male Luer locks, bi-stoppers, Heparian caps, flush devices, and flow regulators. Its broader product selection covers items like joint intervention kits, disposable respirator masks, vaginal dilators (for examinations), Foley catheters, infusion pumps, disposable automatic umbilical cord clamps, single-use infusion connectors and accessories, and burette infusion sets (without needles). Serving medical device manufacturers and other clients, the company operates as a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2022 | Mar 20, 2023 | HK$0.55-62.28% vs estimate | HK$410.77M-55.16% vs estimate |
|---|
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$3.22-HK$0.02 (-0.46%)
Shandong Weigao Group Medical Polymer Company Limited’s quoted price sits in the lower half of its reported 52-week range, 44.76% below the high.
HK$1.47-HK$0.08 (-5.16%)
LifeTech Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.24% below the high.
HK$18.64-HK$0.58 (-3.02%)
Zylox-Tonbridge Medical Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.43% below the high.
HK$13.15-HK$1.10 (-7.72%)
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.59% below the high.
HK$3.74-HK$0.06 (-1.58%)
OrbusNeich Medical Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 23.31% below the high.
HK$3.77-HK$0.15 (-3.83%)
Peijia Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 48.85% below the high.
HK$53.20+HK$0.25 (+0.47%)
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.
HK$5.22-HK$0.36 (-6.37%)
Acotec Scientific Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.93% below the high.
